News

The trial was stopped at the recommendation of an independent data monitoring board based on an interim analysis indicating that it is very unlikely that significant differences in

The company, which has an antibody that targets GM-CSF in preclinical development, said in a presentation at the European Congress of Rheumatology that neutralization of the cytokine may

Initial results from the 2,414 patient phase III trial in advanced chronic heart failure (HF), named ACCLAIM, showed that the study failed to meet its primary endpoint of

The Human Subject Protection and Bioresearch Monitoring (HSP/BIMO) initiative will facilitate the modernization of the regulation of clinical trials and bioresearch monitoring, specifically the protection of human subjects

The first new drug application is for the approval of bazedoxifene, a selective estrogen receptor modulator (SERM) investigated for the prevention of postmenopausal osteoporosis. During menopause women begin

The phase IIb clinical trial is a multi-center, randomized study to evaluate the safety and efficacy of infusional CoFactor and 5-FU versus infusional leucovorin and 5-FU in subjects

The studies, presented at the International Society for Human and Animal Mycology meeting in Paris, show that BAL8557 had no significant impact on the pharmacokinetics of ciclosporin and

The new data were presented at the 15th International HIV Drug Resistance Workshop in Sitges, Spain. The correlation of certain Fuzeon resistance mutations with the observed increases in

In addition, use of the compound was statistically superior in producing pain-free rates as early as 30 minutes, and significantly more patients reached pain-free status at two hours;